AKT1 and lung adenocarcinoma: Activation of the PI3K/Akt pathway is impaired to the benefit of apoptosis upon membrane chol targeting by mβCD, as evidenced in macrophages, lung adenocarcinoma and leukemia cell lines (Motoyama et al., 2009).